doi: 10.1001/archinternmed.2011.182.
A quantitative analysis of adverse events and "overwarning" in drug labeling
Affiliations
- PMID: 21606101
- DOI: 10.1001/archinternmed.2011.182
Item in Clipboard
A quantitative analysis of adverse events and "overwarning" in drug labeling
Arch Intern Med.
.
No abstract available
Comment in
-
Invited commentary--prescription drug label adverse events: a call for prioritization: comment on "A quantitative analysis of adverse events and 'overwarning' in drug labeling".Arch Intern Med. 2011 May 23;171(10):946-7. doi: 10.1001/archinternmed.2011.200. Arch Intern Med. 2011. PMID: 21606102 No abstract available.